MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$634,210K
Net Income
-$27,110K
Net Profit Margin
-4.27%
EPS
-$0.09
Unit: Thousand (K) dollars
Revenue Breakdown
Galafold
Pombiliti Opfolda
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2025-12-31
Net product sales
634,210
Cost of goods sold
72,929
Gross profit
561,281
Research and development
135,843
Selling, general, and administrative
383,487
Changes in fair value of contingent consideration payable
0
Loss on impairment of assets
1,702
Restructuring charges
0
Depreciation and amortization
7,460
Total operating expenses
528,492
Income (loss) from operations
32,789
Interest income
3,317
Interest expense
46,159
Loss on extinguishment of debt
0
Other (expense) income
10,244
Income (loss) before income tax
191
Income tax expense
27,301
Net loss attributable to common stockholders
-27,110
Basic EPS
-0.09
Diluted EPS
-0.09
Basic Average Shares
308,363,768
Diluted Average Shares
308,363,768
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Non Us
$305,941K
US
$215,761K
Non Us
$64,243K
US
$48,265K
Galafold
$521,702K
Pombiliti Opfolda
$112,508K
Net product sales
$634,210K
Gross profit
$561,281K
Cost of goods sold
$72,929K
Income (loss) from
operations
$32,789K
Other (expense)
income
$10,244K
Interest income
$3,317K
Total operating
expenses
$528,492K
Net loss
attributable to common...
-$27,110K
Income (loss) before
income tax
$191K
Interest expense
$46,159K
Selling, general, and
administrative
$383,487K
Research and development
$135,843K
Depreciation and
amortization
$7,460K
Loss on impairment of
assets
$1,702K
Income tax expense
$27,301K
Buy us a coffee
logosdsadsad-svg
AMICUS THERAPEUTICS, INC. (FOLD)
logosdsadsad-svg
AMICUS THERAPEUTICS, INC. (FOLD)